Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Reena Bhakta

Nurse Practitioner, Primary Care Murfreesboro, TN Nurse Practitioner

NPI 1063053254 CMS profile 11109842

1430 Medical Center Pkwy Ste 2B, Murfreesboro, TN 37129

Open in the dashboard

General payments

$11,782

314 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Reena Bhakta of Murfreesboro, TN is reported in the CMS Open Payments database as having received $11,782 across 314 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Primary Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,147 141
2024 General $5,161 135
2023 General $1,368 35
2022 General $105 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Reena Bhakta
  • Nurse Practitioner, Primary Care median
  • Middle half of Nurse Practitioner, Primary Care
  • National median

In program year 2025, general payments to Reena Bhakta were reported at $5,147. Among 4,814 Nurse Practitioner, Primary Care profiles paid that year, the median was $169 and the middle half received between $51 and $499.

Show as a table
Year Reena Bhakta Nurse Practitioner, Primary Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $137 $39–$445 $132
2022 $105 $139 $44–$421 $149
2023 $1,368 $163 $53–$481 $160
2024 $5,161 $176 $54–$511 $164
2025 $5,147 $169 $51–$499 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Janssen Biotech, Inc. $2,039 45 payments
  2. Novartis Pharmaceuticals Corporation $1,944 40 payments
  3. Genzyme Corporation $1,071 17 payments
  4. LEO Pharma Inc. $1,007 21 payments
  5. AbbVie, Inc. $982 28 payments
  6. Sun Pharmaceutical Industries Inc. $644 20 payments
  7. UCB, Inc. $478 15 payments
  8. Regeneron Healthcare Solutions, Inc. $453 17 payments
  9. Incyte Corporation $428 9 payments
  10. Amgen Inc. $312 17 payments
  11. Other $2,425 85 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $11,135 307 payments
  2. Education $647 7 payments
Products named General payments · program years 2022–2025
  1. TREMFYA $2,039 45 payments
  2. COSENTYX $1,161 31 payments
  3. DUPIXENT Immunology $1,112 21 payments
  4. ADBRY $887 18 payments
  5. SKYRIZI $569 13 payments
  6. Bimzelx $478 15 payments
  7. OPZELURA $428 9 payments
  8. DUPIXENT Immunology And Inflammation $361 8 payments
  9. Rhapsido $321 6 payments
  10. Otezla $312 17 payments
  11. Other $4,205 152 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

68

Median for Nurse Practitioner: 389

Drug cost

$746

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ketoconazole Generic 33 $392
Triamcinolone Acetonide Generic 21 $233
Mupirocin Generic 14 $120

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$151,922

Of which drugs: $135,433

Medicare patients

144

Average age 73

Services billed

8,893

83 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 44%
Diabetes 28%
Ischemic heart disease 26%
Chronic kidney disease 26%
Depression 18%
Osteoporosis 16%
COPD 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 26 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $911
$911 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $762
$762 — —
DUPIXENT
  • GENZYME CORPORATION $344
  • Regeneron Healthcare Solutions, Inc. $155
  • SANOFI-AVENTIS U.S. LLC $72
$571 — —
SKYRIZI
  • AbbVie, Inc. $416
$416 — —
ADBRY
  • LEO Pharma Inc. $378
$378 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 26 with Patron

Records

314 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Primary Care in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record